Journal of Cell Science, Vol 108, Issue 1 207-214, Copyright © 1995 by Company of Biologists

JOURNAL ARTICLES

Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle

AJ Gibson, J Karasinski, J Relvas, J Moss, TG Sherratt, PN Strong and DJ Watt
Department of Anatomy, Charing Cross & Westminster Medical School, UK.

Duchenne muscular dystrophy is a primary muscle disease that manifests itself in young boys as a result of a defect in a gene located on the X-chromosome. This gene codes for dystrophin, a normal muscle protein that is located beneath the sarcolemma of muscle fibres. Therapies to alleviate this disease have centred on implanting normal muscle precursor cells into dystrophic fibres to compensate for the lack of this gene and its product. To date, donor cells for implantation in such therapy have been of myogenic origin, derived from paternal biopsies. Success in human muscle, however, has been limited and may reflect immune rejection problems. To overcome this problem the patient's own myogenic cells, with the dystrophin gene inserted, could be used, but this could lead to other problems, since these cells are those that are functionally compromised by the disease. Here, we report the presence of high numbers of dystrophin-positive fibres after implanting dermal fibroblasts from normal mice into the muscle of the mdx mouse-the genetic homologue of Duchenne muscular dystrophy. Dystrophin-positive fibres were also abundant in mdx muscle following the implantation of cloned dermal fibroblasts from the normal mouse. Our results suggest the in vivo conversion of these non-myogenic cells to the myogenic pathway resulting in the formation of dystrophin-positive muscle fibres in the deficient host. The use of dermal fibroblasts may provide an alternative approach to the previously attempted myoblast transfer therapy, which in human trials has yielded disappointing results.

This article has been cited by other articles:

				E. Kimura, J. J. Han, S. Li, B. Fall, J. Ra, M. Haraguchi, S. J. Tapscott, and J. S. Chamberlain Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy Hum. Mol. Genet., August 15, 2008; 17(16): 2507 - 2517. [Abstract] [Full Text] [PDF]

				D. Shi, H. Reinecke, C. E. Murry, and B. Torok-Storb Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells Blood, July 1, 2004; 104(1): 290 - 294. [Abstract] [Full Text] [PDF]

				M. D. Grounds, J. D. White, N. Rosenthal, and M. A. Bogoyevitch The Role of Stem Cells in Skeletal and Cardiac Muscle Repair J. Histochem. Cytochem., May 1, 2002; 50(5): 589 - 610. [Abstract] [Full Text] [PDF]

				J. Gerhart, B. Bast, C. Neely, S. Iem, P. Amegbe, R. Niewenhuis, S. Miklasz, P. F. Cheng, and M. George-Weinstein MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle J. Cell Biol., October 29, 2001; 155(3): 381 - 392. [Abstract] [Full Text] [PDF]

				L Heslop, J. Morgan, and T. Partridge Evidence for a myogenic stem cell that is exhausted in dystrophic muscle J. Cell Sci., January 6, 2000; 113(12): 2299 - 2308. [Abstract] [PDF]

				L. De Angelis, L. Berghella, M. Coletta, L. Lattanzi, M. Zanchi, M. Gabriella , Cusella-, C. Ponzetto, and G. Cossu Skeletal Myogenic Progenitors Originating from Embryonic Dorsal Aorta Coexpress Endothelial and Myogenic Markers and Contribute to Postnatal Muscle Growth and Regeneration J. Cell Biol., November 15, 1999; 147(4): 869 - 878. [Abstract] [Full Text] [PDF]

				A Irintchev, J. Rosenblatt, M. Cullen, M Zweyer, and A Wernig Ectopic skeletal muscles derived from myoblasts implanted under the skin J. Cell Sci., January 11, 1998; 111(22): 3287 - 3297. [Abstract] [PDF]

				G Salvatori, L Lattanzi, M Coletta, S Aguanno, E Vivarelli, R Kelly, G Ferrari, A. Harris, F Mavilio, M Molinaro, et al. Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells J. Cell Sci., January 8, 1995; 108(8): 2733 - 2739. [Abstract] [PDF]